Lymphocyte depletion as a barrier to immunological tolerance

Contributions to Nephrology

Volumn 146, Issue , 2005, Pages 65-72

  Neujahr, David ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; PHYSIOLOGY; PROGNOSIS; REVIEW; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOLOGIC MEMORY; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; PROGNOSIS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 16544371232     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (47)

1. Turka LA, Goguen JE, Gagne JE, Milford EL: Presensitization and the renal allograft recipient. Transplantation 1989;47:234-240.
2. Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, Tary-Lehmnn M: Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999;163:2267-2275.
3. Valujskikh A, Pantenburg B, Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002;2:501-509.
4. Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW: Allograft rejection by primed/memory CD8+ T cells is CD 154 blockade resistant: Therapeutic implications for sensitized transplant recipients. J Immunol 2002;169:4667-4673.
5. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Roelen DL, Claas FH: Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: Relevance for donor selection. Transplantation 2002;73:1286-1290.
6. Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW: Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003;75:1034-1040.
7. Rogers PR, Dubey C, Swain SL: Qualitative changes accompany memory T cell generation: Faster, more effective responses at lower doses of antigen. J Immunol 2000;164:2338-2346.
8. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B: Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 2000;1:47-53.
9. Gudmundsdottir H, Turka LA: A closer look at homeostatic proliferation of CD4+ T cells: Costimulatory requirements and role in memory formation. J Immunol 2001;167:3699-3707.
10. Garcia S, DiSanto J, Stockinger B: Following the development of a CD4 T cell response in vivo: From activation to memory formation. Immunity 1999;11:163-171.
11. Bachmann MF, Barner M, Viola A, Kopf M: Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999;29:291-299.
12. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, et al: Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002;168:29-43.
13. Adams AB, Pearson TC, Larsen CP: Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003;196:147-160.
14. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA: Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 2001;166:973-981.
15. Kishimoto K, Sandner S, Imitola J, Sho M, Li Y, Langmuir PB, et al: Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest 2002;109:1471-1479.
16. Szczech LA, Berlin JA, Feldman HI: The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med 1998;128:817-826.
17. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, et al: Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003;76:120-129.
18. Kuypers DR, Vanrenterghem YF: Monoclonal antibodies in renal transplantation: Old and new. Nephrol Dial Transplant 2004;19:297-300.
19. Rothstein DM, Livak MF, Kishimoto K, Ariyan C, Qian HY, Fecteau S, et al: Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol 2001;166:322-329.
20. Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, et al: Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 2003;52:957-964.
21. Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, et al: A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003;75:844-851.
22. Agha IA, Rueda J, Alvarez A, Singer GG, Miller BW, Flavin K, et al: Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation 2002;73:473-475.
23. Knechtle SJ, Pirsch JD, H. Fechner JJ, Becker BN, Friedl A, Colvin RB, et al: Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study. Am J Transplant 2003;3:722-730.
24. Kieper WC, Jameson SC: Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA 1999;96:13306-13311.
25. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE: Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156:4609-4616.
26. Zimmerman C, Brduscha-Riem K, Blaser C, Zinkernagel RM, Pircher H: Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts. J Exp Med 1996;183: 1367-1375.
27. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A: Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3:33-41.
28. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, et al: Homeostasis of V alpha 14i NKT cells. Nat Immunol 2002;3:966-974.
29. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD: The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999;11:173-181.
30. Muranski P, Chmielowski B, Ignatowicz L: Mature CD4+ T cells perceive a positively selecting class II MHC/peptide complex in the periphery. J Immunol 2000;164:3087-3094.
31. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R: Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999;286:1377-1381.
32. Ploix C, Lo D, Carson MJ: A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4T cells and progression of autoimmunity. J Immunol 2001;167:6724-6730.
33. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD: Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002;195:1523-1532.
34. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, et al: Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002;195:1515-1522.
35. Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, et al: Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: Development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol 2003;171:5853-5864.
36. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J: Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 2000;192:549-556.
37. Murali-Krishna K, Ahmed R: Cutting edge: Naive T cells masquerading as memory cells. J Immunol 2000;165:1733-1737.
38. Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000;192:557-564.
39. Prlic M, Blazar BR, Khoruts A, Zell T, Jameson SC: Homeostatic expansion occurs independently of costimulatory signals. J Immunol 2001;167:5664-5668.
40. Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, et al: Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004;10:87-92.
41. Cozzo C, Larkin J 3rd, Caton AJ: Cutting edge: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol 2003;171:5678-5682.
42. Takeda I, Ine S, Killeen N, Ndhlovu LC, Murata K, Satomi S, et al: Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 2004;172:3580-3589.
43. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, et al: Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995;59:256-262.
44. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, et al: Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999;68:480-484.
45. Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, et al: Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002;74:1405-1409.
46. Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB: Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003;19:503-514.
47. Lechler RI, Garden OA, Turka LA: The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003;3:147-158.